13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001697013
申报总市值
US$19.3亿
US$19.3亿
85 檔
26.3%
在 Q3 2025 申报期间，Eversept Partners, LP（CIK: 0001697013）向美国 SEC 提交的 Form 13F 报告显示，其追踪之股票投资组合总市值达 US$19.3亿，共持有 85 个公开申报仓位。
在 Q3 2025，Eversept Partners, LP 操作展现出积极扩展与加仓意向。本季共新建仓 44 个新仓位，并对 22 个既有持股进行加仓（合计增持 66 档），相较减仓与清仓仓位显著占优。
在资产配置集中度方面，Eversept Partners, LP 的前 5 大核心持股（包含 QQQ, UTHR, GSK 等）合计占整体申报市值的 26.3%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | QQQ | Invesco Qqq Trust Series 1 | ETF-科技型 | 9.52% | -3.49% | +33.57% | |
| 2 | UTHR | United Therapeutics CORP | 股票-医疗保健 | 7.78% | -0.17% | +353.83% | |
| 3 | GSK | Gsk Plc-spon Adr | 股票-医疗保健 | 6.31% | -3.89% | -5.44% | |
| 4 | NTRA | Natera Inc | 股票-医疗保健 | 5.76% | -1.58% | -34.75% | |
| 5 | VERA | Vera Therapeutics Inc | 股票-其他 | 5.62% | +0.32% | +17.83% | |
| 6 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 3.68% | -0.38% | -14.71% | |
| 7 | PCVX | Vaxcyte Inc | 股票-其他 | 3.53% | -0.93% | +9.51% | |
| 8 | QURE | uniQure N.V. | 股票-其他 | 3.53% | — | — | |
| 9 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 3.28% | +0.01% | +11.72% | |
| 10 | VRDN | Viridian Therapeutics Inc | 股票-其他 | 2.86% | +0.05% | +1.14% | |
| 11 | ZIMV | Zimvie Inc | 股票-其他 | 2.71% | — | — | |
| 12 | ABVX | Abivax Sa-adr | 股票-其他 | 2.50% | +0.83% | — | |
| 13 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 2.43% | +0.23% | -8.53% | |
| 14 | RVTY | Revvity Inc | 股票-医疗保健 | 2.38% | +0.09% | -22.73% | |
| 15 | TVTX | Travere Therapeutics Inc | 股票-其他 | 2.33% | +1.50% | +7.77% | |
| 16 | TECH | Bio-techne CORP | 股票-医疗保健 | 2.27% | -0.28% | +50.08% | |
| 17 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 2.06% | +0.46% | +37.58% | |
| 18 | TEVA | Teva Pharmaceutical-sp Adr | 股票-医疗保健 | 1.90% | — | +29.52% | |
| 19 | BRKR | Bruker CORP | 股票-医疗保健 | 1.54% | +0.35% | -18.13% | |
| 20 | CYH | Community Health Systems Inc | 股票-其他 | 1.54% | +0.01% | +13.11% | |
| 21 | UNH | Unitedhealth Group Inc | 股票-医疗保健 | 1.49% | +0.53% | +3.43% | |
| 22 | DHR | Danaher CORP | 股票-医疗保健 | 1.36% | — | +323.36% | |
| 23 | GERN | Geron CORP | 股票-其他 | 1.19% | -0.24% | +72.11% | |
| 24 | ELV | Elevance Health Inc | 股票-医疗保健 | 1.00% | — | +137.21% | |
| 25 | PODD | Insulet CORP | 股票-医疗保健 | 0.97% | -0.41% | — | |
| 26 | RGEN | Repligen CORP | 股票-医疗保健 | 0.97% | -0.65% | +464.38% | |
| 27 | NAMS | NewAmsterdam Pharma Company N.V. | 股票-其他 | 0.96% | — | +17.89% | |
| 28 | RNAGBP | Avidity Biosciences Inc | 股票-其他 | 0.91% | — | — | |
| 29 | NVO | Novo-nordisk A/s-spons Adr | 股票-医疗保健 | 0.83% | +0.42% | NEW | |
| 30 | ILMN | Illumina Inc | 股票-医疗保健 | 0.81% | — | -37.72% | |
| 31 | AVTR | Avantor Inc | 股票-医疗保健 | 0.80% | -1.23% | EXIT | |
| 32 | LQDA | Liquidia CORP | 股票-其他 | 0.76% | +0.42% | +35.45% | |
| 33 | MNKD | Mannkind CORP | 股票-其他 | 0.76% | — | +192.78% | |
| 34 | BCRX | Biocryst Pharmaceuticals Inc | 股票-其他 | 0.72% | -0.56% | +13.74% | |
| 35 | SPRY | Ars Pharmaceuticals Inc | 股票-其他 | 0.68% | +0.10% | — | |
| 36 | ICLR | ICON Public Limited Company | 股票-医疗保健 | 0.66% | -0.40% | EXIT | |
| 37 | REGN | Regeneron Pharmaceuticals | 股票-医疗保健 | 0.65% | — | +26.15% | |
| 38 | EOLS | Evolus Inc | 股票-其他 | 0.62% | — | +26.04% | |
| 39 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 0.56% | — | +27.88% | |
| 40 | CNC | Centene CORP | 股票-医疗保健 | 0.55% | -0.19% | EXIT | |
| 41 | BMRN | Biomarin Pharmaceutical Inc | 股票-医疗保健 | 0.55% | +0.12% | — | |
| 42 | ARDX | Ardelyx Inc | 股票-其他 | 0.54% | -0.26% | — | |
| 43 | BIIB | Biogen Inc | 股票-医疗保健 | 0.50% | — | — | |
| 44 | CPRX | Catalyst Pharmaceuticals Inc | 股票-医疗保健 | 0.48% | — | — | |
| 45 | DVAX | Dynavax Technologies CORP | 股票-其他 | 0.47% | — | -42.07% | |
| 46 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 0.44% | -0.12% | — | |
| 47 | ETNBGBP | 89bio Inc | 股票-其他 | 0.40% | — | +66.30% | |
| 48 | HQY | Healthequity Inc | 股票-医疗保健 | 0.34% | -0.23% | EXIT | |
| 49 | GPCR | Structure Therapeutics Inc | 股票-其他 | 0.32% | +0.20% | +67.50% | |
| 50 | ✓ | Merus N V | 股票-其他 | 0.31% | — | -63.30% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | UTHR | United Therapeutics CORP | +6% | +353.83% | 加仓 |
| 2 | QQQ | Invesco Qqq Trust Series 1 | +2.5% | +33.57% | 加仓 |
| 3 | PCVX | Vaxcyte Inc | +1.4% | +9.51% | 加仓 |
| 4 | VERA | Vera Therapeutics Inc | +1% | +17.83% | 加仓 |
| 5 | VRDN | Viridian Therapeutics Inc | +1% | +1.14% | 加仓 |
| 6 | IONS | Ionis Pharmaceuticals Inc | +0.9% | -8.53% | 加仓 |
| 7 | TVTX | Travere Therapeutics Inc | +0.8% | +7.77% | 加仓 |
| 8 | CLDX | Celldex Therapeutics Inc | +0.8% | +37.58% | 加仓 |
| 9 | RGEN | Repligen CORP | +0.7% | +464.38% | 加仓 |
| 10 | TECH | Bio-techne CORP | +0.6% | +50.08% | 加仓 |
| 11 | AVTR | Avantor Inc | +0.6% | -39.43% | 加仓 |
| 12 | LQDA | Liquidia CORP | +0.5% | +35.45% | 加仓 |
| 13 | ICLR | ICON Public Limited Company | +0.5% | -14.80% | 加仓 |
| 14 | ZIMV | Zimvie Inc | +0.4% | — | 不变 |
| 15 | MNKD | Mannkind CORP | +0.4% | +192.78% | 加仓 |
| 16 | NAMS | NewAmsterdam Pharma Company N.V. | +0.4% | +17.89% | 加仓 |
| 17 | ELV | Elevance Health Inc | +0.3% | +137.21% | 加仓 |
| 18 | ALEC | Alector Inc | +0.2% | -25.04% | 加仓 |
| 19 | ETNBGBP | 89bio Inc | +0.2% | +66.30% | 加仓 |
| 20 | ✓ | Merus N V | 0% | -63.30% | 减仓 |
| 21 | IFRX | InflaRx N.V. | 0% | +5.50% | 加仓 |
| 22 | STRO | Sutro Biopharma, Inc. | 0% | -0.04% | 减仓 |
| 23 | EHTH | Ehealth Inc | 0% | — | 加仓 |
| 24 | FTRE | Fortrea Holdings Inc | -0.1% | — | 减仓 |
| 25 | NVAX | Novavax Inc | -0.1% | — | 减仓 |
| 26 | ZBIO | Zenas Biopharma Inc | -0.1% | -51.23% | 减仓 |
| 27 | MRVI | Maravai Lifesciences Hldgs-a | -0.2% | -54.63% | 减仓 |
| 28 | GOSS | Gossamer Bio Inc | -0.3% | -45.44% | 减仓 |
| 29 | TEVA | Teva Pharmaceutical-sp Adr | -0.3% | +29.52% | 减仓 |
| 30 | HUM | Humana Inc | -0.5% | -61.82% | 减仓 |
| 31 | BRKR | Bruker CORP | -0.6% | -18.13% | 加仓 |
| 32 | MOH | Molina Healthcare Inc | -0.7% | -54.03% | 减仓 |
| 33 | CYH | Community Health Systems Inc | -0.8% | +13.11% | 减仓 |
| 34 | RVTY | Revvity Inc | -0.8% | -22.73% | 加仓 |
| 35 | BCRX | Biocryst Pharmaceuticals Inc | -0.9% | +13.74% | 减仓 |
| 36 | CNC | Centene CORP | -1.6% | -43.68% | 减仓 |
| 37 | SNDX | Syndax Pharmaceuticals Inc | -1.6% | -14.71% | 减仓 |
| 38 | HCA | Hca Healthcare Inc | -2.1% | +11.72% | 减仓 |
| 39 | HQY | Healthequity Inc | -2.8% | -66.39% | 减仓 |
| 40 | GSK | Gsk Plc-spon Adr | -4% | -5.44% | 减仓 |
| 41 | NTRA | Natera Inc | -7.1% | -34.75% | 减仓 |
| 42 | QURE | uniQure N.V. | — | NEW | 新建仓 |
| 43 | SPY | Ss Spdr S&p 500 ETF Trust-us | — | EXIT | 清仓 |
| 44 | ABVX | Abivax Sa-adr | — | NEW | 新建仓 |
| 45 | INSP | Inspire Medical Systems Inc | — | EXIT | 清仓 |
| 46 | PTGX | Protagonist Therapeutics Inc | — | EXIT | 清仓 |
| 47 | UNH | Unitedhealth Group Inc | — | NEW | 新建仓 |
| 48 | DHR | Danaher CORP | — | NEW | 新建仓 |
| 49 | NBIX | Neurocrine Biosciences Inc | — | EXIT | 清仓 |
| 50 | GERN | Geron CORP | — | NEW | 新建仓 |
根据 SEC 官方 Form 13F 申报备案，Eversept Partners, LP 在 Q3 2025 季度的美股持仓总市值约为 US$19.3亿，共申报了 85 个公开持股仓位。
在 Q3 2025 季度，Eversept Partners, LP 按市值排列的前三大核心持股分别为：QQQ (9.5%)、UTHR (7.8%)、GSK (6.3%)。其中最大持股仓位 QQQ 占据整体投资组合约 9.5% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
QURE
市值: US$5121.2万
本季最大获利了结 / 清仓标的
SPY
前期市值: US$4301.7万
在 Q3 2025 季度中，Eversept Partners, LP 共进行了 99 项持仓异动，包含新建仓 44 个仓位、加仓 22 个仓位、减仓 18 个仓位以及清仓 15 个仓位。 其中最大新建仓标的为 QURE。 本季清仓仓位包含 SPY。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。